Nano-biomimetic carriers are implicated in mechanistic evaluation of intracellular gene delivery
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/srep41507.pdf
Reference60 articles.
1. Davidson, B. L. & McCray, P. B. Current prospects for RNA interference-based therapies. Nature Reviews Genetics 12, 329–340, doi: 10.1038/nrg2968 (2011).
2. Fonseca, S. B., Pereira, M. P. & Kelley, S. O. Recent advances in the use of cell-penetrating peptides for medical and biological applications. Advanced Drug Delivery Reviews 61, 953–964, doi: 10.1016/j.addr.2009.06.001 (2009).
3. Kim, D. H. & Rossi, J. J. Strategies for silencing human disease using RNA interference. Nature reviews. Genetics 8, 173–184, doi: 10.1038/nrg2006 (2007).
4. Mastrobattista, E., van der Aa, M. A., Hennink, W. E. & Crommelin, D. J. Artificial viruses: a nanotechnological approach to gene delivery. Nature reviews. Drug discovery 5, 115–121, doi: 10.1038/nrd1960 (2006).
5. Li, S. D. & Huang, L. Gene therapy progress and prospects: Non-viral gene therapy by systemic delivery. Gene Therapy 13, 1313–1319, doi: 10.1038/sj.gt.3302838 (2006).
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Delivery of nucleic acids using nanomaterials;Molecular Biomedicine;2023-12-14
2. DNAi-peptide nanohybrid smart particles target BCL-2 oncogene and induce apoptosis in breast cancer cells;Biomedicine & Pharmacotherapy;2023-10
3. Creating Artificial Viruses Using Self-assembled Proteins and Polypeptides;Physical Virology;2023
4. Recent advances in gene therapy-based cancer monotherapy and synergistic bimodal therapy using upconversion nanoparticles: Structural and biological aspects;Biomedicine & Pharmacotherapy;2022-12
5. Design and preparation of a theranostic peptideticle for targeted cancer therapy: Peptide-based codelivery of doxorubicin/curcumin and graphene quantum dots;Nanomedicine: Nanotechnology, Biology and Medicine;2022-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3